FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/13/2026
Back to search
Official data from USPTO
BEYOND CDMO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BEYOND CDMO
ST13
US500000079407434Class
1, 9, 42
Filing
79407434
Registration
8131585
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
08/13/2026
Trademark type
Word
Nice classes
1, 9, 42
Filing date
06/28/2024
Registration date
02/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
08/13/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
SE
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
NorthX Biologics AB
Representatives
Alexander Lazouski Lazouski IP LLC
Technical classification
Nice Classes
Class 1Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industry and scienceespecially proteinsenzymes and modifications thereof.
Class 9
Scientific apparatus and instruments being medical laboratory research instruments for controllingmeasuringacceleratingtransporting chemicals for use in biochemical and genetic research; Scientific apparatus and instrumentsapparatus and instruments being medical laboratory research instruments for use in gene therapyplasmid DNA productioncell banking and DNA sequencing
Class 42
Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy product processes; research and development of vaccines and medicines; research and development in the field of diagnostic preparations; development of new products being biological drugs and advanced therapy product processes; medical research laboratory services; research on the subject of pharmaceuticals; provision of information and data relating to medical preparation research and development; scientific research servicestechnology advisory services related to pharmaceutical research and developmentdevelopment of gene therapy productsgenetic biologic products; product research and development in the field of cell banking; product research and development in the field of plasmid DNA production; product research and development in the field of DNA sequencing; medical and scientific researchconducting clinical trials for others; medical and scientific researchconducting clinical trials for others for pharmaceutical products; scientific and medical research on cell banks
Publications
History of USPTO decisions and trademark events.
38 publications found
FIMP
FINAL DISPOSITION PROCESSED
08/13/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/10/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/09/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/23/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/23/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/10/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/23/2025
PUBO
PUBLISHED FOR OPPOSITION
12/23/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/17/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/11/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/29/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/28/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/28/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/28/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/26/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
11/26/2025
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
11/26/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/26/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/26/2025
RFNT
REFUSAL PROCESSED BY IB
09/12/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/26/2025
RFRR
REFUSAL PROCESSED BY MPU
08/26/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/26/2025
CNRT
NON-FINAL ACTION WRITTEN
08/25/2025
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
02/24/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/09/2025
CNRT
NON-FINAL ACTION WRITTEN
01/08/2025
DOCK
ASSIGNED TO EXAMINER
12/26/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/02/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/02/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/02/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/02/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/02/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/24/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/24/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/24/2024
Continuous trademark protection
Get notified about every new filing that threatens BEYOND CDMO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.